MedTrakRx

Pharmacy Benefit Management

[MedTrakRx @MedTrakRx]

The FDA has approved Haegarda for routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks in adolescent and adult patients. #HAE

[MedTrakRx @MedTrakRx]

The first generic for Pataday has been launched!Olopatadine ophthalmic solution 0.2% is available in pharmacies now. #AllergicConjunctivitis

[MedTrakRx @MedTrakRx]

Generic versions of #Strattera will be on pharmacy shelves soon! The FDA has approved AB-rated atomoxetine for the treatment of #ADHD

[MedTrakRx @MedTrakRx]

FDA approves new biologic treatment option for #RheumatoidArthritis.#Kevzara will be added to MedTrakRx’s Best-in-Class #SpecialtyRx program

[MedTrakRx @MedTrakRx]

#Actemra is the first FDA-approved therapy for the treatment of giant cell arteritis, a condition affecting blood vessels. #vasculitis

[MedTrakRx @MedTrakRx]

Access to #CysticFibrosis therapy is growing! The FDA has expanded the approved use of #Kalydeco to treat 33 gene mutations.

[MedTrakRx @MedTrakRx]

Tymlos, new specialty drug for the treatment of osteoporosis has been approved. Expect to hear more later this month.#osteoporosis

[MedTrakRx @MedTrakRx]

A second treatment option for ALS (Lou Gehrig’s disease) will soon be available! The FDA approved Radicava on May 5, 2017. #ALS

[MedTrakRx @MedTrakRx]

Listening to the "Arnold" at Asembia 2017. #Asembia2017 #Governator

[MedTrakRx @MedTrakRx]

Generic Vytorin is now available from three
manufacturers! Ezetimibe/simvastatin tablets became available on April
26, 2017. #Vytorin

[MedTrakRx @MedTrakRx]

Just a reminder, Saturday April 29th
is National Prescription Drug Take Back Day!

[MedTrakRx @MedTrakRx]

A second biosimilar to Remicade has been approved by the FDA! Renflexis was approved for multiple indications on April 21, 2017.

[MedTrakRx @MedTrakRx]

#ForeverRoyal

[MedTrakRx @MedTrakRx]

MedTrakRx Clinical Team had a great time attending the 2017 AMCP Expo. Our pharmacists learned a lot about newly approved drug products.

[MedTrakRx @MedTrakRx]

Pump the Brakes on Spending with MedTrakRx's New Drug to Market Policy! https://t.co/dJFugnfHUh

[MedTrakRx @MedTrakRx]

Dupixent was approved by the FDA on March 28, 2017. It is the second drug approved for the treatment of atopic dermatitis in the last year.

[MedTrakRx @MedTrakRx]

MedTrakRx is looking forward to attending Asembia's 2017 Specialty Pharmacy Summit in Las Vegas again this year! #Asembia2017

[MedTrakRx @MedTrakRx]

MedTrakRx is proud to again co-host the ProAm Golf Tournament benefiting Folds of Honor. Tournament is Sept. 25th @ the Milburn Country Club

[MedTrakRx @MedTrakRx]

MedTrakRx team enjoying Orlando, Fl at the 2017 PBMI Conference. #PBMI2017

[MedTrakRx @MedTrakRx]

Congrats to our 2016 MedTrakRx Award Winners: Tracy Johnson, Alex Saxen and Bart Hoolehan III. Great Job Everyone!